股本结构
单位：万股
| 公告日期 | 2024-11-13 | 2024-08-14 | 2024-05-09 | 2024-03-07 | 2024-03-07 | 2023-11-09 |
|---|---|---|---|---|---|---|
| 证券总股本 | 3974.42 | 3941.72 | 3927.24 | 3927.24 | 3909.35 | 3862.46 |
| 普通股本 | 3974.42 | 3941.72 | 3927.24 | 3927.24 | 3909.35 | 3862.46 |
| 优先股 | 未披露 | 1.02 | 1.02 | 未披露 | 1.02 | 1.02 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2024-03-04 | 2023-12-31 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-11-13 | 3974.42 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Issuance of common stock upon vesting of restricted stock units
Conversion of convertible preferred stock into common stock
|
2024-09-30 |
| 2024-08-14 | 3941.72 | 1.02 |
更多>>
From March 31, 2024 to June 30, 2024
Issuance of common stock from employee stock plan
Issuance of common stock upon vesting of restricted stock units
|
2024-06-30 |
| 2024-05-09 | 3927.24 | 1.02 |
更多>>
From December 31, 2023 to March 31, 2024
Issuance of common stock through "at the market" offering, net
Issuance of common stock upon vesting of restricted stock units
|
2024-03-31 |
| 2024-03-07 | 3927.24 | 未披露 | 定期报告 | 2024-03-04 |
| 2024-03-07 | 3909.35 | 1.02 |
更多>>
From December 31,2022 to December 31,2023
Issuance of common stock upon exercise of stock options and from employee stock plan
Issuance of common stock through "at the market" offering, net
Issuance of common stock upon vesting of restricted stock units
|
2023-12-31 |
| 2023-11-09 | 3862.46 | 1.02 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock upon vesting of restricted stock units
|
2023-09-30 |
| 2023-08-14 | 3858.04 | 1.02 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock upon exercise of stock options and from employee stock plan
Issuance of common stock through "at the market" offering, net
Issuance of common stock upon vesting of restricted stock units
|
2023-06-30 |
| 2023-05-09 | 3841.09 | 1.02 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
|
2023-03-31 |
| 2023-03-14 | 3841.09 | 未披露 | 定期报告 | 2023-03-06 |
| 2023-03-14 | 3834.51 | 1.02 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock upon exercise of stock options and from employee stock plan
Issuance of common stock through "at the market" offering, net
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock upon vesting of early exercised stock options
|
2022-12-31 |
| 2022-11-10 | 3819.73 | 未披露 | 定期报告 | 2022-11-01 |
| 2022-11-10 | 3790.28 | 1.02 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock upon exercise of stock options
Issuance of common stock through "at the market" offering, net
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock upon vesting of early exercised stock options
|
2022-09-30 |
| 2022-08-09 | 3755.82 | 未披露 | 定期报告 | 2022-08-01 |
| 2022-08-09 | 3755.43 | 1.02 |
更多>>
From March 31, 2022 to June 30, 2022
Exercise of stock options to purchase common stock
Vesting of restricted stock units
Vesting of early exercise of stock options
|
2022-06-30 |
| 2022-04-27 | 3748.83 | 未披露 | 定期报告 | 2022-04-19 |
| 2022-05-10 | 3748.62 | 1.02 |
更多>>
From December 31, 2021 to March 31, 2022
Exercise of stock options to purchase common stock
Vesting of restricted stock units
Vesting of early exercise of stock options
|
2022-03-31 |
| 2022-03-17 | 3748.58 | 未披露 | 定期报告 | 2022-03-04 |
| 2022-03-17 | 3742.49 | 1.02 |
更多>>
From December 31, 2020 to December 31, 2021
Conversion of convertible preferred stock into common stock upon Merger
Issuance of convertible preferred stock to former stockholders of Sunesis upon Merger
Vesting of restricted stock units
Exercise of warrants and stock options to purchase common stock
Vesting of early exercise of stock options
Issuance of common stock net of issuance costs
Issuance of common stock to former stockholders of Sunesis upon Merger
|
2021-12-31 |
| 2021-11-10 | 3731.17 | 未披露 | 定期报告 | 2021-11-03 |
| 2021-11-10 | 3728.12 | 1.02 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of warrants and stock options to purchase common stock
Vesting of early exercise of employee stock options
|
2021-09-30 |
| 2021-08-12 | 3722.62 | 未披露 | 定期报告 | 2021-08-02 |
| 2021-08-12 | 3714.08 | 1.02 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of warrants and stock options to purchase common stock
Vesting of early exercise of employee stock options
|
2021-06-30 |
| 2021-05-28 | 3709.27 | 1.02 | 定期报告 | 2021-05-26 |
| 2021-05-13 | 3704.32 | 未披露 | 定期报告 | 2021-05-07 |
| 2021-05-13 | 3703.63 | 1.02 |
更多>>
From December 31, 2020 to March 31, 2021
Conversion of convertible preferred stock into common stock upon Merger
Issuance of convertible preferred stock to former stockholders of Sunesis upon Merger
Exercise of warrants and stock options to purchase common stock
Vesting of early exercise of employee stock options
Issuance of common stock net of issuance costs
Issuance of common stock to former stockholders of Sunesis upon Merger
|
2021-03-31 |
| 2021-02-24 | 3700.00 | 未披露 |
更多>>
Immediately following the Effective Time, there were approximately 37.0 million shares of Common Stock outstanding (post Reverse Stock Split). Immediately following the Effective Time, the former Viracta stockholders owned approximately 86.05% of the outstanding shares of Common Stock, and the Company’s stockholders immediately prior to the Merger, whose shares of Common Stock remain outstanding after the Merger, owned approximately 13.95% of the outstanding shares of Common Stock.
|
2021-02-25 |
| 2021-02-24 | 1810.80 | 1.00 |
更多>>
From December 31,2019 to December 31,2020
Issuance of $13,800 of common stock, net of issuance cost of $1,167
Issuance of common stock upon conversion of preferred stock
Issuance of common stock under employee stock purchase plans
|
2020-12-31 |
| 2020-11-30 | 1809.31 | 未披露 | 定期报告 | 2020-11-27 |
| 2020-11-16 | 1809.30 | 1.00 |
更多>>
From June 30, 2020 to September 30, 2020
Conversion of preferred stock to common stock
Issuance of common and preferred stock in underwritten
|
2020-09-30 |
| 2020-09-02 | 1809.31 | 未披露 |
更多>>
On September 2, 2020, Sunesis Pharmaceuticals, Inc. (the “Company”) filed a Certificate of Amendment to Amended and Restated Certificate of Incorporation of Sunesis Pharmaceuticals, Inc. (the “Amendment”) to effect a one-for-ten reverse stock split of its outstanding common stock, effective as of September 2, 2020 (the “Reverse Stock Split”). A series of alternate amendments to effect the Reverse Stock Split was approved by the Company’s stockholders at its Annual Meeting of Stockholders held on June 16, 2020, and the specific one-for-ten ratio was subsequently approved by the Company’s Board of Directors on August 17, 2020.
|
2020-09-03 |
| 2020-08-11 | 18093.10 | 未披露 | 定期报告 | 2020-08-06 |
| 2020-07-31 | 16356.71 | 未披露 |
更多>>
1.Common stock offered by the company 52,173,913 shares.
2.The number of shares of common stock to be outstanding immediately after this offering as shown above is based on 111,393,236 shares of common stock outstanding as of March 31, 2020.
|
2020-07-31 |
| 2020-08-11 | 11146.50 | 2.00 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock under employee stock purchase plans
|
2020-06-30 |
| 2020-04-28 | 11139.32 | 未披露 | 定期报告 | 2020-02-28 |
| 2020-03-10 | 11139.30 | 2.00 |
更多>>
From December 31,2018 to December 31,2019
Issuance of $38,000 of common stock, $10,000 preferred stock,net of issuance cost of $3,400
Issuance of common stock upon conversion of preferred stock
Issuance of $473 of common stock through controlled equity offering facilities, net of issuance costs of $9
Issuance of common stock from vesting of restricted stock awards
Issuance of common stock under employee stock purchase plans
|
2019-12-31 |
| 2019-08-07 | 11132.00 | 未披露 | 定期报告 | 2019-08-01 |
| 2019-07-15 | 10091.18 | 未披露 | 定期报告 | 2019-07-15 |
| 2019-05-08 | 7252.80 | 未披露 | 定期报告 | 2019-05-01 |
| 2019-03-07 | 6757.81 | 未披露 | 定期报告 | 2019-03-01 |
| 2019-03-07 | 3747.40 | 1.80 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of $6,068 of common stock through controlled equity offering facilities, net of issuance costs of $77
Issuance of common stock from vesting of restricted stock awards
Issuance of common stock under employee stock purchase plans
Issuance of common stock pursuant to stock option exercises
|
2018-12-31 |
| 2019-01-22 | 3742.15 | 1.77 | 定期报告 | 2018-09-30 |
| 2018-08-08 | 3613.70 | 未披露 | 定期报告 | 2018-08-02 |
| 2018-04-25 | 3437.12 | 未披露 | 定期报告 | 2018-04-10 |
| 2018-03-09 | 3434.89 | 未披露 | 定期报告 | 2018-03-01 |
| 2018-03-09 | 3429.10 | 1.77 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of $15,000 of common stock, $5,000 of preferred stock, and warrants in underwritten offering, net of issuance costs about $1,500
Issuance of common stock upon conversion of preferred stock
Issuance of $14,468 of common stock through controlled equity offering facilities, net of issuance costs of $289
Issuance of common stock under employee stock purchase plans
Issuance of common stock pursuant to stock option exercises
|
2017-12-31 |
| 2017-11-02 | 3424.83 | 未披露 | 定期报告 | 2017-10-27 |
| 2017-10-26 | 2398.87 | 1.52 | 定期报告 | 2017-09-30 |
| 2017-07-27 | 2351.32 | 未披露 | 定期报告 | 2017-07-21 |
| 2017-04-20 | 2146.05 | 未披露 | 定期报告 | 2017-04-04 |
| 2017-04-20 | 2093.69 | 未披露 | 定期报告 | 2017-03-01 |
| 2017-03-09 | 2092.45 | 未披露 | 定期报告 | 2017-02-24 |
| 2017-03-09 | 2092.50 | 1.79 |
更多>>
from December 31, 2015 to December 31, 2016
Issuance of common stock upon conversion of preferred stock
Issuance of preferred stock
Issuance of $21,852 of common stock in underwritten offering, net of issuance costs of $1,497
Issuance of $269 of common stock through controlled equity offering facilities, net of issuance costs of $5
Issuance of common stock under employee stock purchase plans
On September 7, 2016, the Company effected a one-for-six reverse split of its common stock (the "Reverse Split"), as previously authorized and approved at the annual meeting of stockholders on June 7, 2016.
|
2016-12-31 |
| 2016-11-03 | 2087.87 | 未披露 |
更多>>
In October 2016, the Company completed underwritten offerings of (i) 5,675,825 shares of its common stock, that included the exercise of the underwriter's over-allotment option of 740,325 shares, at a price to the public of $3.85 per share, and (ii) 1,558 shares of our non-voting Series C Convertible Preferred Stock (“Series C Stock”) at a price to the public of $3,850.00 per share.
|
2016-10-24 |
| 2016-09-07 | 1450.24 | 未披露 |
更多>>
The company to effect a one-for-six reverse stock split of its outstanding common stock, effective as of September 7, 2016.
|
2016-09-08 |
| 2016-07-29 | 8701.44 | 未披露 | 定期报告 | 2016-07-22 |
| 2016-04-25 | 8693.50 | 未披露 | 定期报告 | 2016-04-11 |
| 2016-03-14 | 8651.78 | 未披露 | 定期报告 | 2016-02-26 |
| 2016-03-14 | 8651.80 | 2020.00 |
更多>>
from December 31, 2014 to December 31, 2015
Issuance of preferred stock
Issuance of $9,236 of common stock in underwritten offering, net of issuance costs of $527
Issuance of $18,564 of common stock through controlled equity offering facilities, net of issuance costs of $439
Issuance of common stock pursuant to warrant exercises
Issuance of common stock pursuant to stock option exercises
Issuance of common stock under employee stock purchase plans
Issuance of common stock to employees
|
2015-12-31 |
| 2015-07-30 | 7547.09 | 未披露 | 定期报告 | 2015-07-30 |
| 2015-05-05 | 7296.03 | 未披露 | 定期报告 | 2015-04-30 |
| 2015-04-28 | 7061.74 | 未披露 | 定期报告 | 2015-04-10 |
| 2015-03-12 | 6773.98 | 未披露 | 定期报告 | 2015-02-27 |
| 2015-03-12 | 6610.20 | 未披露 |
更多>>
From December 31,2013 to December 31,2014
Issuance of $43,013 of common stock and warrants in underwritten offering, net of issuance costs of $2,989
Issuance of $14,734 of common stock through controlled equity offering facilities, net of issuance costs of $442
Issuance of common stock pursuant to warrant exercises
Issuance of common stock pursuant to stock option exercises
Issuance of common stock under employee stock purchase plans
Issuance of common stock to employees
|
2014-12-31 |
| 2014-11-10 | 6194.91 | 未披露 | 定期报告 | 2014-10-31 |
| 2014-08-05 | 6044.30 | 未披露 | 定期报告 | 2014-07-25 |
| 2014-05-07 | 6021.70 | 未披露 | 定期报告 | 2014-04-30 |
| 2014-05-07 | 6016.27 | 未披露 | 定期报告 | 2014-03-31 |
| 2014-03-06 | 6009.48 | 未披露 | 定期报告 | 2014-03-04 |
| 2014-03-06 | 5434.40 | 未披露 |
更多>>
from December 31, 2012 to December 31, 2013
Issuance of $12,357 of common stock through controlled equity offering facilities, net of issuance costs of $371
Issuance of common stock pursuant to warrant exercises
Issuance of common stock pursuant to stock option exercises
Issuance of common stock under employee stock purchase plans
Issuance of common stock to employees
|
2013-12-31 |
| 2013-11-12 | 5398.25 | 未披露 | 定期报告 | 2013-10-31 |
| 2013-08-02 | 5169.43 | 未披露 | 定期报告 | 2013-07-31 |
| 2013-04-25 | 5160.91 | 未披露 | 定期报告 | 2013-04-09 |
| 2013-03-13 | 5158.38 | 未披露 | 定期报告 | 2013-02-28 |
| 2013-03-13 | 5156.50 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Issuance of $18,124 of common stock through controlled equity offering facilities, net of issuance costs of $504
Issuance of common stock pursuant to warrant exercises
Issuance of common stock pursuant to stock option exercises
Issuance of common stock under employee stock purchase plans
Issuance of common stock to employees
|
2012-12-31 |
| 2012-11-08 | 5150.03 | 未披露 | 定期报告 | 2012-10-31 |
| 2012-08-09 | 4710.50 | 未披露 | 定期报告 | 2012-07-31 |
| 2012-05-15 | 4692.42 | 未披露 | 定期报告 | 2012-04-30 |
| 2012-03-14 | 4682.01 | 未披露 | 定期报告 | 2012-03-01 |
| 2012-03-14 | 4677.40 | 未披露 |
更多>>
from December 31, 2010 to December 31, 2011
Issuance of $4,178 of common stock through controlled equity offering facilities, net of issuance costs of $125
Issuance of common stock under employee stock purchase plans
Issuance of common stock to employees
|
2011-12-31 |
| 2011-08-11 | 4671.37 | 未披露 | 定期报告 | 2011-07-31 |
| 2011-03-29 | 4602.75 | 未披露 | 定期报告 | 2011-03-15 |
| 2011-02-14 | 4434.41 | 未披露 |
更多>>
a 1 for 6 split of it's common stock
|
2011-02-15 |
| 2010-11-04 | 26606.48 | 未披露 | 定期报告 | 2010-10-15 |
| 2010-08-13 | 22182.16 | 未披露 | 定期报告 | 2010-07-31 |
| 2010-04-29 | 5798.12 | 未披露 | 定期报告 | 2010-04-15 |
| 2005-09-27 | 2145.58 | 未披露 | 定期报告 | 2005-09-27 |
From June 30, 2024 to September 30, 2024
Issuance of common stock upon vesting of restricted stock units
Conversion of convertible preferred stock into common stock
From March 31, 2024 to June 30, 2024
Issuance of common stock from employee stock plan
Issuance of common stock upon vesting of restricted stock units
From December 31, 2023 to March 31, 2024
Issuance of common stock through "at the market" offering, net
Issuance of common stock upon vesting of restricted stock units
From December 31,2022 to December 31,2023
Issuance of common stock upon exercise of stock options and from employee stock plan
Issuance of common stock through "at the market" offering, net
Issuance of common stock upon vesting of restricted stock units
From June 30, 2023 to September 30, 2023
Issuance of common stock upon vesting of restricted stock units
From March 31, 2023 to June 30, 2023
Issuance of common stock upon exercise of stock options and from employee stock plan
Issuance of common stock through "at the market" offering, net
Issuance of common stock upon vesting of restricted stock units
From December 31, 2022 to March 31, 2023
Issuance of common stock upon exercise of stock options
Issuance of common stock upon vesting of restricted stock units
From December 31, 2021 to December 31, 2022
Issuance of common stock upon exercise of stock options and from employee stock plan
Issuance of common stock through "at the market" offering, net
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock upon vesting of early exercised stock options
From June 30, 2022 to September 30, 2022
Issuance of common stock upon exercise of stock options
Issuance of common stock through "at the market" offering, net
Issuance of common stock upon vesting of restricted stock units
Issuance of common stock upon vesting of early exercised stock options
From March 31, 2022 to June 30, 2022
Exercise of stock options to purchase common stock
Vesting of restricted stock units
Vesting of early exercise of stock options
From December 31, 2021 to March 31, 2022
Exercise of stock options to purchase common stock
Vesting of restricted stock units
Vesting of early exercise of stock options
From December 31, 2020 to December 31, 2021
Conversion of convertible preferred stock into common stock upon Merger
Issuance of convertible preferred stock to former stockholders of Sunesis upon Merger
Vesting of restricted stock units
Exercise of warrants and stock options to purchase common stock
Vesting of early exercise of stock options
Issuance of common stock net of issuance costs
Issuance of common stock to former stockholders of Sunesis upon Merger
From June 30, 2021 to September 30, 2021
Exercise of warrants and stock options to purchase common stock
Vesting of early exercise of employee stock options
From March 31, 2021 to June 30, 2021
Exercise of warrants and stock options to purchase common stock
Vesting of early exercise of employee stock options
From December 31, 2020 to March 31, 2021
Conversion of convertible preferred stock into common stock upon Merger
Issuance of convertible preferred stock to former stockholders of Sunesis upon Merger
Exercise of warrants and stock options to purchase common stock
Vesting of early exercise of employee stock options
Issuance of common stock net of issuance costs
Issuance of common stock to former stockholders of Sunesis upon Merger
Immediately following the Effective Time, there were approximately 37.0 million shares of Common Stock outstanding (post Reverse Stock Split). Immediately following the Effective Time, the former Viracta stockholders owned approximately 86.05% of the outstanding shares of Common Stock, and the Company’s stockholders immediately prior to the Merger, whose shares of Common Stock remain outstanding after the Merger, owned approximately 13.95% of the outstanding shares of Common Stock.
From December 31,2019 to December 31,2020
Issuance of $13,800 of common stock, net of issuance cost of $1,167
Issuance of common stock upon conversion of preferred stock
Issuance of common stock under employee stock purchase plans
From June 30, 2020 to September 30, 2020
Conversion of preferred stock to common stock
Issuance of common and preferred stock in underwritten
On September 2, 2020, Sunesis Pharmaceuticals, Inc. (the “Company”) filed a Certificate of Amendment to Amended and Restated Certificate of Incorporation of Sunesis Pharmaceuticals, Inc. (the “Amendment”) to effect a one-for-ten reverse stock split of its outstanding common stock, effective as of September 2, 2020 (the “Reverse Stock Split”). A series of alternate amendments to effect the Reverse Stock Split was approved by the Company’s stockholders at its Annual Meeting of Stockholders held on June 16, 2020, and the specific one-for-ten ratio was subsequently approved by the Company’s Board of Directors on August 17, 2020.
1.Common stock offered by the company 52,173,913 shares.
2.The number of shares of common stock to be outstanding immediately after this offering as shown above is based on 111,393,236 shares of common stock outstanding as of March 31, 2020.
From March 31, 2020 to June 30, 2020
Issuance of common stock under employee stock purchase plans
From December 31,2018 to December 31,2019
Issuance of $38,000 of common stock, $10,000 preferred stock,net of issuance cost of $3,400
Issuance of common stock upon conversion of preferred stock
Issuance of $473 of common stock through controlled equity offering facilities, net of issuance costs of $9
Issuance of common stock from vesting of restricted stock awards
Issuance of common stock under employee stock purchase plans
from December 31, 2017 to December 31, 2018
Issuance of $6,068 of common stock through controlled equity offering facilities, net of issuance costs of $77
Issuance of common stock from vesting of restricted stock awards
Issuance of common stock under employee stock purchase plans
Issuance of common stock pursuant to stock option exercises
from December 31, 2016 to December 31, 2017
Issuance of $15,000 of common stock, $5,000 of preferred stock, and warrants in underwritten offering, net of issuance costs about $1,500
Issuance of common stock upon conversion of preferred stock
Issuance of $14,468 of common stock through controlled equity offering facilities, net of issuance costs of $289
Issuance of common stock under employee stock purchase plans
Issuance of common stock pursuant to stock option exercises
from December 31, 2015 to December 31, 2016
Issuance of common stock upon conversion of preferred stock
Issuance of preferred stock
Issuance of $21,852 of common stock in underwritten offering, net of issuance costs of $1,497
Issuance of $269 of common stock through controlled equity offering facilities, net of issuance costs of $5
Issuance of common stock under employee stock purchase plans
On September 7, 2016, the Company effected a one-for-six reverse split of its common stock (the "Reverse Split"), as previously authorized and approved at the annual meeting of stockholders on June 7, 2016.
In October 2016, the Company completed underwritten offerings of (i) 5,675,825 shares of its common stock, that included the exercise of the underwriter's over-allotment option of 740,325 shares, at a price to the public of $3.85 per share, and (ii) 1,558 shares of our non-voting Series C Convertible Preferred Stock (“Series C Stock”) at a price to the public of $3,850.00 per share.
The company to effect a one-for-six reverse stock split of its outstanding common stock, effective as of September 7, 2016.
from December 31, 2014 to December 31, 2015
Issuance of preferred stock
Issuance of $9,236 of common stock in underwritten offering, net of issuance costs of $527
Issuance of $18,564 of common stock through controlled equity offering facilities, net of issuance costs of $439
Issuance of common stock pursuant to warrant exercises
Issuance of common stock pursuant to stock option exercises
Issuance of common stock under employee stock purchase plans
Issuance of common stock to employees
From December 31,2013 to December 31,2014
Issuance of $43,013 of common stock and warrants in underwritten offering, net of issuance costs of $2,989
Issuance of $14,734 of common stock through controlled equity offering facilities, net of issuance costs of $442
Issuance of common stock pursuant to warrant exercises
Issuance of common stock pursuant to stock option exercises
Issuance of common stock under employee stock purchase plans
Issuance of common stock to employees
from December 31, 2012 to December 31, 2013
Issuance of $12,357 of common stock through controlled equity offering facilities, net of issuance costs of $371
Issuance of common stock pursuant to warrant exercises
Issuance of common stock pursuant to stock option exercises
Issuance of common stock under employee stock purchase plans
Issuance of common stock to employees
from December 31, 2011 to December 31, 2012
Issuance of $18,124 of common stock through controlled equity offering facilities, net of issuance costs of $504
Issuance of common stock pursuant to warrant exercises
Issuance of common stock pursuant to stock option exercises
Issuance of common stock under employee stock purchase plans
Issuance of common stock to employees
from December 31, 2010 to December 31, 2011
Issuance of $4,178 of common stock through controlled equity offering facilities, net of issuance costs of $125
Issuance of common stock under employee stock purchase plans
Issuance of common stock to employees
a 1 for 6 split of it's common stock